Alimta

Updated: New York: Apr 18 08:00London: Apr 18 13:00Tokyo: Apr 18 21:00 : Regions Top Worldwide Regions Asia Australia & New Zealand Canada Europe Germany Japan Latin America U.K.

U.S.

Markets Economy/Politics Commentary Sports Culture RESOURCES: Bloomberg TV Bloomberg Radio Markets U.S.

E-Mail This Story Printer-Friendly Format Adobe to Buy Macromedia for $3.4 Billion, Adding Flash Web-Design Software Bank of America Profit Rises 75 Percent as FleetBoston Bolsters Results U.S.

Stock-Index Futures Drop; Shares of Intel, General Motors Decline Lilly's 1st-Quarter Profit Rises on Higher Sales, Lower Costs April 18 (Bloomberg) - Eli Lilly & Co., seeking to reduce its reliance on the schizophrenia medicine Zyprexa, said first- quarter profit rose 84 percent because of higher sales and lower expenses.

Net income increased to $736.6 million, or 68 cents a share, from $400.4 million, or 37 cents, a year earlier, when Lilly had acquisition-related costs.

Sales rose 4 percent to $3.5 billion, the Indianapolis-based company said today in a statement distributed by PR Newswire.

Lilly is counting on newer medicines such as the attention- deficit drug Strattera, the cancer treatment Chief Executive Sidney Taurel has said he expects sales from eight products introduced in the last three ye...

Read more...